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Abstract
Transhydrogenase is a proton pump found in the membranes of bacteria and animal mitochondria. The solution structure
of the expressed, 21.5 kDa, NADP(H)-binding component (dIII) of transhydrogenase from Rhodospirillum rubrum has been
solved by NMR methods. This is the first description of the structure of dIII from a bacterial source. The protein adopts a
Rossmann fold: an open, twisted, parallel L-sheet, flanked by helices. However, the binding of NADP to dIII is profoundly
different to that seen in other Rossmann structures, in that its orientation is reversed: the adenosine moiety interacts with the
first LKLKL motif, and the nicotinamide with the second. Features in the structure that might be responsible for changes in
nucleotide-binding affinity during catalysis, and for interaction with other components of the enzyme, are identified. The
results are compared with the recently determined, high-resolution crystal structures of human and bovine dIII which also
show the reversed nucleotide orientation. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: Transhydrogenase; Membrane protein; Proton translocation; Nuclear magnetic resonance structure; Nucleotide binding
1. Introduction
Transhydrogenase couples the transfer of reduc-
ing equivalents (hydride-ion equivalents) between
NAD(H) and NADP(H) to the translocation of pro-
tons across a membrane (for review, see [1]) :
Hout NADHNADPIHin NAD NADPH
1
The enzyme is located in the inner mitochondrial
membrane of animal cells, and in the cytoplasmic
membrane of some species of bacteria. Usually, the
reaction is driven from left to right by the proton
electrochemical gradient (vp) generated by respira-
tory (or photosynthetic) electron transfer. In bacte-
ria, transhydrogenase provides NADPH for biosyn-
thesis [2], but in mammalian mitochondria its
function is probably to control £ux though the tri-
carboxylic acid cycle [3].
Transhydrogenase consists of three components:
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an NAD(H)-binding portion (designated dI), a hy-
drophobic, membrane-embedded portion (dII), and
an NADP(H)-binding portion (dIII). Both dI and
dIII protrude from the same side of the membrane
(the cytoplasmic side in bacteria). In mammalian mi-
tochondria, transhydrogenase comprises a single
polypeptide; in bacteria the enzyme is composed of
two or three polypeptides. However, gene sequences
indicate that, unlike other proteins of oxidative phos-
phorylation, transhydrogenases in mitochondria and
bacteria have a similar subunit organisation. Soluble,
recombinant forms of dI and dIII have been ex-
pressed using the cloned genes from Rhodospirillum
rubrum [4,5], Escherichia coli [6], beef heart [7] and
human heart [8]. Recombinant dI speci¢cally binds
NAD/NADH, and recombinant dIII speci¢cally
binds NADP/NADPH. A mixture of dI and dIII
(from the same or even from di¡erent species) forms
a complex which catalyses rapid hydride transfer be-
tween NAD(H) and NADP(H) or their analogues [5^
8]. The rate of reaction catalysed by the dI:dIII com-
plex is limited by slow dissociation of nucleotide
from dIII [5].
In complete transhydrogenase, vp is believed to
drive the reaction by modulating the binding a⁄n-
ities of the enzyme for NADP and NADPH [9,10].
Although hydride transfer in the dI:dIII complex is
well characterised (e.g. [11,12]), our knowledge of the
associated conformational events and the mechanism
by which these are coupled to proton translocation
has been severely limited by the lack of available
structure information. High resolution crystal struc-
tures of the dIII protein from bovine [13] and human
[1,14] mitochondria were recently described. Second-
ary structure predictions of bacterial dIII (from R.
rubrum [15] and E. coli [16]) based on NMR analysis
were generally consistent with the crystal structures
of the mammalian proteins. However, there were ap-
parent di¡erences between the preliminary ‘global
fold’ of E. coli dIII (ecdIII) obtained from NMR
data [16], and the crystallographically determined
fold of the bovine and human proteins. Here, we
present the solution structure of the NADP-bound
form of dIII from R. rubrum transhydrogenase
(rrdIII). The fold of the protein and its mode of nu-
cleotide binding are compared with those in the
mammalian dIII structures. Knowledge of the solu-
tion structure of rrdIII allows an improved interpre-
tation of our earlier NMR studies of the interactions
of the protein with dI, and of the e¡ect of the redox




Recombinant rrdIII, in either unlabelled, 15N-la-
belled, or 13C, 15N-labelled forms, was expressed in
E. coli BL21(DE3) from the plasmid pNIC2 and pu-
ri¢ed by column chromatography [5,17]. It contained
approx. 1 mole of tightly bound NADP(H) per mole
of protein. This nucleotide was not isotopically la-
belled in the labelled protein preparations, due to
exchange with the 2 WM NADP present in all the
column and dialysis bu¡ers. To ensure sample homo-
geneity, rrdIII was incubated with AcPdAD and dI
in order to oxidise any bound NADPH to NADP,
and then re-puri¢ed [17]. Samples of between 500
and 800 WM protein were prepared in bu¡er contain-
ing 20 mM HEPES (pH 7.2), 2 WM NADP, 50 WM
4-(2-aminoethyl)benzenesulphonyl £uoride (AEBSF),
0.1% (w/v) sodium azide and 50 Wg/ml chloramphe-
nicol. These concentrations of azide, AEBSF and
chloramphenicol did not a¡ect the catalytic activity
of the protein. The solvent was 92% H2O/8% 2H2O
or 99.9% 2H2O, as required. In all cases, pH values
were taken from the meter readings, without correc-
tion for the deuterium isotope e¡ect. Samples were
¢lter sterilised using a 0.22 Wm ¢lter (Millipore) im-
mediately prior to addition to the NMR tube.
2.2. General NMR parameters
All NMR experiments were performed on a Var-
ian UnityPlus spectrometer, operating at 599.983
MHz for 1H, except for the HNHB, which was per-
formed on a Bruker AMX spectrometer operating at
500.13 MHz for 1H. Quadrature detection was
achieved using either the States time-proportional-
phase-incrementation or sensitivity-enhanced proto-
cols. All experiments were performed at 30‡C. Spec-
tra were transformed using Vnmr (Varian) software
for the 3D spectra and UXNMR (Bruker) soft-
ware for the 2D spectra. Peaks were picked using
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NMRCompass (MSI). Chemical shifts were refer-
enced indirectly to external tetramethylsilane. 1H,
15N HSQC spectra were acquired before and after
each experiment to ensure that the protein had not
degraded while in the spectrometer.
2.3. Assignment of resonances
The initial assignment of main chain 1HN, 15N,
13CK, 1HK, 13CP and side chain 13CL resonances was
described in [17]. Further side chain assignments
were achieved using HNHB [18], CCH-TOCSY [19]
with tm = 20 ms, HC(C)H-COSY and (H)CCH-
COSY [20] experiments. Stereospeci¢c assignment
was performed manually on the HL protons, using
the HNHB and HACAHB-COSY spectra [21]. The
protons in the bound nucleotide were assigned using
a 13C, 15N-double ¢ltered, double-quantum ¢ltered
COSY experiment [22] in 2H2O, 13C, 15N-double ¢l-
tered NOESY experiments (tm = 50, 100 and 300 ms)
in H2O and a 13C, 15N-double ¢ltered NOESY ex-
periment in 2H2O (tm = 300 ms). These experiments
utilised the ¢ltering method of [23], with ¢ltering
applied both before and after the NOESY mixing
time.
2.4. Calculation of torsion angles
Backbone P and i dihedral angles were calculated
from the chemical shift index, as given in [15]. Elim-
ination of certain ranges of the side chain torsion
angle (M1) was achieved from analysis of the
HNHB and HACAHB-COSY spectra, and from
the zero crossing point of a CT-HMQC experiment
[24].
2.5. NOESY experiments
Protein-protein distance restraints were calculated
from the following experiments: 2D 1H-1H NOESY
(tm = 200 ms) in 2H2O; 3D 15N-resolved NOESY-
HSQC (tm = 200 ms, 5 mm probe, solvent suppres-
sion by sensitivity enhancement) [25] ; 3D 15N-re-
solved NOESY-HSQC (tm = 200 ms, 10 mm probe,
solvent suppression by Watergate [26]); 3D 13C-re-
solved NOESY-HMQC (tm = 300 ms) and 3D 13C-
resolved HMQC-NOESY (tm = 300 ms), both in
2H2O and 1H2O, derived from [27]. Due to the rapid
relaxation of magnetisation in rrdIII, both the 4D
13C, 13C-resolved HMQC-NOESY-HMQC [27] and
the 4D 13C, 15N-resolved HMQC-NOESY-HSQC
[28] (tm values of 100^350 ms) spectra contained
very few inter-residue peaks. Instead, we used the
two 3D 13C-resolved NOESY spectra, and cross-
matched the two common dimensions to give a
peak list equivalent to that from a 4D 13C, 13C-re-
solved experiment.
Distance restraints between protein and nucleotide
were calculated primarily from a 13C F1-¢ltered, F3-
edited NOESY experiment (tm = 250 ms) [23]. We
also used the method of [23] to produce 13C, 15N
F1-¢ltered, 15N-edited NOESY-HSQC and 13C, 15N
F1-¢ltered, 13C-edited NOESY-HSQC spectra.
2.6. Calculation of structures
Over 200 intra-protein NOEs were assigned unam-
biguously from the pair of 13C-resolved NOESY-
HMQC and HMQC-NOESY spectra. These NOEs
were used to generate a starting structure and the
remaining NOEs were assigned, and distances calcu-
lated, using ARIA [29] in X-PLOR version 3.851
Table 1







Medium range (di;i2 to di;i4) 210
Long range (di;i5 and greater) 446





Average violation (all unambiguous NOEs) 0.022 Aî
Violations v 0.5 Aî (max. 0.57 Aî ) 2
(C) RMSD (ten lowest energy structures)
CK only (residues 32^202) 1.01 Aî
All atoms (residues 32^202) 1.69 Aî
NADP alone 1.39 Aî
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[30]. Long-range dNN and dKN NOEs were identi¢ed
from the NOESY-HSQC experiments performed on
large samples of rrdIII (3.5 ml of 800 WM 15N-la-
belled protein in the 10 mm probe). These together
with the side chain to side chain NOEs were used to
orient the L-strands relative to one another and to
place each helix on the correct side of the L-sheet.
Restraints used in the ¢nal structural calculations
are shown in Table 1, and the NOE distribution in
Fig. 1B. In addition, a small number of very weak
NOEs across the L-strands were identi¢ed, for which
an upper distance limit of 7 Aî was used in the struc-
tural calculations. Standard pseudoatom corrections
were applied to the methyl protons. The P and i
angles for all assigned residues (except Gly, Asn
and Pro) were restrained to the K-helix or L-sheet
Fig. 1. (A) Sequence and secondary structure elements of rrdIII. h, helix; L, L-strand. Residues invariant in 11 other published se-
quences are shown in bold lettering. (B) Matrix representation of inter-residue NOE restraints, showing the distribution of long range
NOEs.
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regions of the Ramachandran plot on the basis of the
chemical shift index [15]. Hydrogen bond donors
were picked using the slowly exchanging amides
noted previously [15]. Hydrogen bond acceptors
were picked using preliminary structures in X-
PLOR. In total, 59 hydrogen bonds were predicted,
and restraints (two per hydrogen bond, where
rNHÿO = 1.8^2.2 Aî and rNÿO = 2.2^3.3 Aî ) were in-
cluded in the ¢nal stages of re¢nement.
One hundred protein structures, in the absence of
NADP, were determined in X-PLOR 3.851 [30],
using a protocol in which certain atoms of each res-
idue (CK, HK, N, HN, C=, and CL, CQ where present)
were embedded using distance geometry. The re-
maining atoms were placed by template ¢tting, and
then the atomic co-ordinates were allowed to evolve
under the applied NOE distance and dihedral con-
straints during a series of high temperature annealing
steps. The nucleotide and protein were docked using
molecular dynamics, whilst holding the nucleotide
rigid. Following energy minimisation, the structures
were then subjected to three further iterations of sim-
ulated annealing. An average structure was calcu-
lated by simultaneously re¢ning the ten lowest-en-
ergy structures in a high-temperature, simulated
annealing protocol, and applying an additional con-
straint in order to minimise the root-mean-square
di¡erence between the aligned co-ordinates (non-
crystalline symmetry restraints applied to all atoms
of residues 29^202).
Analysis of the ¢nal ten lowest-energy structures
was performed using the AQUA and PROCHECK-
NMR packages [31]. Figures were generated using
MOLSCRIPT [32].
3. Results and discussion
3.1. NMR resonance assignments and structure
determinations
Assignments were previously obtained for all back-
bone resonances of rrdIII, apart from those from the
¢rst 14 amino acids, HN and N of Tyr147 and the N
signals from the eight proline residues [17]. In the
current work, with the exception of the ¢rst 14 res-
idues, the side chain 1H and 13C signals from Ala,
Ser, Val, Thr, Leu, and Ile residues were assigned
completely, along with all Asn/Asp to CL-HL, and
all Gln/Glu to CQ -HQ . Problems arising from rapid
relaxation and spectral overlap were encountered in
the assignment of several Met CQ -HQ , Arg CQ -HQ and
CN-HN, Pro CQ -HQ and CN-HN, and Lys CN-HN and
CO-HO. Assignment of HN and HO was achieved for all
5 Tyr, and HN was assigned for six out of the ten Phe
residues using the two-dimensional NOESY spectra
in 2H2O (Phe 110, 119, 162, 179, 180, 188). All the
non-exchangeable protons of the bound NADP
were assigned, with the exception of the adenine ri-
bose H4P.
The data used to generate the family of solution
structures are summarised in Table 1, together with
relevant properties of the ten lowest energy struc-
tures. The co-ordinates of the averaged structure
have been deposited in the Brookhaven PDB library
(accession code 1e3t).
3.2. The protein fold
Recombinant dIII of R. rubrum contains 203 ami-
no acid residues. It folds into a single, compact do-
main, of approx. 35 AîU35 AîU45 Aî . Fig. 1 shows
the protein sequence, the identi¢ed elements of sec-
ondary structure, and the distribution of inter-resi-
due NOEs. The family of solution structures (Fig. 2)
is well de¢ned by the NOE-derived restraints. The
overall structure (Fig. 3) has the common dinucleo-
Fig. 2. Ensemble of the CK traces (residues 26^203) of the ten
lowest energy structures of rrdIII, aligned using the CK atoms
of residues 32^202. The bound NADP of each structure is
shown in red. The ¢rst 25 residues are highly disordered and
are not shown.
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tide-binding fold, or Rossmann fold, found in many
soluble dehydrogenases [33,34]. Thus, rrdIII contains
an open, twisted L-sheet of six parallel strands (L1 to
L6). Looking across the L-sheet, the strands appear
in the order L3-2-1-4-5-6, and they are £anked by
helices or loops (A to F). The two LKLKL motifs
(L1-L3 and L4-L6) are linked by a ‘cross-over’ helix
(C) between the C-terminus of strand L3 and the N-
terminus of L4. Helices A, B and F lie on one side of
the L-sheet, whilst helix C, helix D/loop D and loop
E are on the opposite side. Helix D/loop D forms an
extended structure which protrudes from the sheet.
Loop E passes over loop D (see Fig. 4) and the nu-
cleotide-binding site. The N-terminal 28 amino acids
of rrdIII are largely unstructured, with few inter-res-
idue NOEs. Residues 29^35 curl around the protein,
with Val31-Ala33 forming a short, extended strand,
which lies parallel to L6. This is linked to L1 by an
additional helix, designated helix 0, which lies on the
same face of the L-sheet as helices A, B and F. The
overall fold of rrdIII, determined by NMR methods,
is remarkably similar to those revealed in the X-ray
structures of the equivalent proteins derived from
mammalian sources, notably human dIII (hsdIII
[1,14]) and bovine dIII (btdIII) [13]. In view of these
similarities, the perceived di¡erences between the
crystal structures of hsdIII and btdIII, and the pre-
liminary ‘global fold’ of ecdIII [16], might simply
result from an insu⁄cient number of NOEs used to
model the E. coli protein. The solution and crystal
structures share similar conformations in their more
unusual features, such as helix D/loop D and loop E;
these might play an important role in the function of
the protein (see below).
Fig. 3. Stereo cartoon of rrdIII fold. K-Helices (0, A^C, F; red) and L-strands (L1^L6; green) are superimposed on the backbone CK
trace of residues 29^203 of the averaged structure. Also labelled are loops D and E, but the single, weakly helical turns D1, DP and E
are omitted for clarity. The bound NADP is shown in ball-and-stick representation, with the nicotinamide ring at the left-hand side.
Fig. 4. Structure of helix D/loop D and loop E. The stereo view depicts the backbone CK trace of the averaged structure, for residues
Gly129-Gly158 (helix D/loop D) in grey, and Arg165-Asn183 (loop E) in red. Residues Asn131, Asp132, Ala168, Ser169 and Tyr171
are shown in ball-and-stick representation, along with the predicted hydrogen bonds between them (turquoise, dotted lines).
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3.3. The unusual mode of nucleotide binding in
transhydrogenase dIII
In the classical Rossmann fold, the dinucleotide is
bound in a groove across the C-termini of the L-
strands. In the case of NAD(P)(H)-binding proteins,
the adenosine moiety lies in a cleft between strands
L1 and L2, and the pyrophosphate group contacts
the loop connecting L1 and helix A. This loop con-
tains the Gly-X-Gly-X-X-Gly (NAD(H)-binding) or
Gly-X-Gly-X-X-Ala/Val (NADP(H)-binding) ‘¢nger-
print’ sequence [35]. In several NADP(H)-binding
proteins, one or more positively charged residues
are located near the C-terminal end of L2, and inter-
act with the 2P-phosphate of the adenosyl ribose [36].
All known transhydrogenase sequences contain the
NADP(H) ¢ngerprint (residues Gly54-Val59 of
rrdIII), and an invariant pair of basic residues
(His85, Arg90 in rrdIII). It was therefore predicted
that NADP would be bound to E. coli dIII in the
conventional manner [37].
A list of contacts between rrdIII and the bound
NADP, derived mainly from the NOE data, is giv-
en in Table 2. Intra-nucleotide NOEs show that the
nicotinamide ring is syn with respect to its sugar,
while the adenosine is in the anti con¢guration. Sur-
prisingly, however, the adenosine lies over the C-ter-
mini of strands L4 and L5, and the nicotinamide lies
over the C-terminus of strand L2, protruding out
into the solvent above the short L3. Although there
are relatively few NOEs between the protein and the
nicotinamide ring, the identi¢ed contacts provide
very adequate constraints for the ribose rings and
the adenine, and allow us to be con¢dent of this
unusual orientation of the bound nucleotide, which
is the opposite to that found in other NAD(P)(H)-
binding proteins. The same result was obtained in the
crystal structures of the mammalian dIII proteins
[1,13,14].
As in the classical Rossmann fold, the ¢ngerprint
sequence of rrdIII is located at the C-terminus of
strand L1. However, due to the reversed orientation
of the NADP, the backbone amide groups of this
sequence do not make the extensive contacts with the
pyrophosphate seen in the classical binding mode.
The ¢rst glycine (Gly54) of the ¢ngerprint, which
would normally form a sharp bend, instead adopts
an extended conformation within strand L1. The
bend away from the strand occurs at the next resi-
due, Tyr55. The aromatic ring of this residue, which
is also invariant in known dIII sequences, points out-
wards from the protein, and is probably involved in
hydrophobic interactions with the adenosine, while
its backbone amide lies within H-bonding distance
of the nucleotide pyrophosphate. The second glycine
(Gly56) allows close approach of the adenosine,
rather than the pyrophosphate. As a consequence
of the novel orientation of the nucleotide, the invar-
iant His85 and Arg90, contrary to the prediction of
[37], do not lie close to the 2P-phosphate of the ad-
enosyl ribose.
The most important region of rrdIII for binding
the nucleotide pyrophosphate lies at the C-terminus
of strand L4. Residues in this region of the protein
have an equivalent role to those at the C-terminus of
strand L1 in the classical Rossmann fold. An invar-
iant glycine (Gly129) allows a 90‡ bend in the poly-
Table 2
Proton connectivities between rrdIII and bound NADP
dIII residue protons NADP atoms
(A) NOEs
Tyr55 HD+, HE+ adenine H8
Val59 HG2+ adenine H8
Ala60 HB+ adenine H2
Val87 HA nicotinamide H7+
HB nicotinamide H2
HG1+, HG2+ nicotinamide H2, nicotinamide ribose
H2
Ala88 HA nicotinamide ribose H2, H5+
Arg90 HA nicotinamide H7+
Gly129 HA1, HA2 adenosyl ribose H1
Val133 HG2+ nicotinamide ribose H5+, H4, H3
Ile163 HG2+ adenine H2
Lys164 HA adenine H2, adenosyl ribose H1
HB+ adenosyl ribose H1
Gly170 HA2 adenosyl ribose H5Q
Tyr171 HD+, HE+ nicotinamide ribose H1
Ala191 HA, HB+ adenine H2
(B) Hydrogen bonds
Val133 HN nicotinamide O1
Lys164 HZ+ adenosyl 2P-phosphate (OP+)
X-PLOR atom nomenclature is used. The NOEs were divided
into two classes on the basis of their intensities. All but three
were weak, and the upper limit of each of these restraints was
set to 5 Aî . The upper distance limit of the three stronger
NOEs (Val133 HG2+/nicotinamide ribose H3; Gly170 HA2/ad-
enosyl ribose H5Q ; and Ala191 HB+/adenine H2) was set to
3.5 Aî .
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peptide backbone, and displays NOEs to the adeno-
syl ribose. The backbone amide groups of Asn131,
Asp132 and Val133 are all potential H-bond donors
to the pyrophosphate. Although amide protons in-
volved in intra-protein H-bonding are not expected
to exchange rapidly with solvent, the protons from
these residues, except Val133, exchanged s 90%
within 5 h [15]. This may be a consequence of the
exchange of bound nucleotide with that in the bu¡er
(koff = 0.03 s31 [5]) allowing the amide groups to be
exposed to solvent for short periods. The invariant
Asn131 ful¢ls the role of the second glycine in the
classical ¢ngerprint, allowing the close approach of
the pyrophosphate to the protein backbone. The
counterpart of the Val/Ala of the NADP(H) ¢nger-
print is less conserved (Thr134 in rrdIII), and has no
obvious role in nucleotide binding. In proteins where
NAD(P)(H) is bound in the conventional orienta-
tion, the pyrophosphate lies over the N-terminus of
helix A, but in rrdIII, the pyrophosphate is posi-
tioned over the N-terminus of the helix D/loop D
structure.
One lysyl O-NH3 group was assigned from the
15N-resolved NOESY spectrum to Lys164. The pro-
ton signals from such groups are not usually ob-
served, due to fast exchange with solvent. A likely
explanation is that Lys164 forms an H-bond with the
2P-phosphate of the adenosyl ribose. The side chain
of the adjacent Arg165 might also interact with the
2P-phosphate, but it has not been fully assigned and
is therefore not well constrained in the solution struc-
ture. These residues might be responsible for the
NADP(H)-binding speci¢city of the protein.
The adenine ring of the nucleotide is well con-
strained by NOEs to the side chains of residues on
both sides of its binding pocket. By contrast, the
nicotinamide ring exhibits NOEs only from the pro-
S face (to Val87). Access to the pro-R face is, how-
ever, obstructed by the backbone of residues Gly89-
Met91. The structure in this region is thus consistent
with the stereospeci¢city of hydride transfer in the
complete enzyme, to and from the more exposed
pro-S side of NADP(H) [38].
Two tyrosine residues, Tyr55 and Tyr171, lie on
either edge of the binding cleft. Tyr55 is invariant,
while Tyr171 is strongly conserved (Tyr/Phe). In the
crystal structure of hsdIII, the corresponding Tyr
residues, along with the equivalent of Arg90 in
rrdIII, form a cluster over the pyrophosphate, which
may serve to prevent nucleotide release. Although
the side chain of Arg90 is less constrained by
NOEs, a similar clustering of residues may occur in
rrdIII. In the family of NMR structures, Tyr55 lies
within 4^5 Aî of the adenine ring and Tyr171 is ap-
prox. 5^6 Aî from the nicotinamide ring. NOEs were
detected between the Tyr55 ring and the adenosyl H8
proton, and between the Tyr171 ring and the nicotin-
amide ribose H1P proton (Table 2). It is therefore
possible that the two rings participate in stacking
interactions with the respective nucleotide rings. We
previously measured changes in magnetic environ-
ment of the amide groups of rrdIII upon replacing
bound NADP with NADPH [15]. The magnetic
e¡ects correspond to a conformational change during
the hydride transfer step. The residues most a¡ected
were located in the vicinity of the nucleotide binding
site (including Tyr55 and Tyr171), in helix D/loop D,
and in loop E. A stacking interaction between
Tyr171 and the nicotinamide ring could provide a
mechanism for the protein to distinguish between
bound NADP and NADPH. Following oxidation
or reduction of the bound nucleotide, a change in the
orientation of Tyr171 resulting from altered stacking
could produce conformational changes in helix D/
loop D and loop E, which in turn might be trans-
mitted to dII via interactions with its surface-exposed
loops (see below).
3.4. Interactions between dIII and dI
Direct hydride transfer between NAD(H) and
NADP(H) requires that the C4 atoms of the two
nicotinamide rings must come close to each other
[11]. Experiments were performed to investigate the
e¡ect on the magnetic environment of the amide
groups of rrdIII upon binding of rrdI [15]. Eight
residues that showed preferential broadening are
clustered around the L3 edge of the L-sheet, suggest-
ing that this region forms at least part of the dI
binding site on dIII (Fig. 5). In a model of rrdI based
on the crystal structure of alanine dehydrogenase
[39], the dihydronicotinamide ring of NADH is lo-
cated in a cleft [40]. It is proposed that the ridge-like
region of dIII bearing the nicotinamide ring of
NADP inserts into the cleft of dI to bring the two
nicotinamide C4 atoms into apposition.
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3.5. Interactions between dIII and dII
The face of rrdIII comprising helices 0, A, and F is
polar, with few conserved residues, and is likely to be
exposed to the solvent in intact transhydrogenase.
The opposite side of the protein, including helix C,
helix D/loop D and loop E, is more hydrophobic and
has more conserved residues, including a conserved
acidic patch. It therefore seems a better candidate to
contain the sites of interaction of dIII with dI and
dII. Given the likelihood that dI interacts with the L3
end of the L-sheet (see above), we suggest that sur-
face loops of dII might interact with parts of helix D/
loop D and loop E.
In isolated dIII, loop E lies over the pyrophos-
phate of the bound NADP (Figs. 3 and 4). Nucle-
otide release is extremely slow, and we have sug-
gested that this conformation of dIII corresponds
to an ‘occluded’ state of the intact enzyme [1,14].
The occluded state catalyses rapid hydride transfer
between dI and dIII, without coupling to proton
translocation [41]. During the catalytic cycle, the in-
tact enzyme probably undergoes conformational
changes between the occluded state and an ‘open’
state, from which nucleotide can readily dissociate.
Such a conformational change is likely to involve
loop E and the neighbouring helix D/loop D, and
could be linked to the proton translocation process
by the interaction of these structures with surface
loops of dII. There are possible hydrogen bonds be-
tween residues of helix D/loop D and loop E:
Asn131 side chain amide to backbone carbonyls of
Ala168 and Ser169, and Tyr171 amide to Asp132
side chain carboxylate.
A key role in controlling the binding and release of
NADP(H) is likely to be performed by the invariant
acidic residue, Asp132, located in helix D/loop D
(Fig. 4). Asp132 is positioned immediately below
the pyrophosphate of the bound NADP(H), an un-
expected place to ¢nd an acidic residue. Its side chain
carboxylate is a potential hydrogen-bond acceptor
from the amide of Tyr171 in the rrdIII solution
structure, and a corresponding interaction is seen in
the hsdIII crystal structure. Solvent access to Asp132
is severely restricted by the ring of Tyr171, the bound
nucleotide, and other residues of helix D/loop D and
loop E. We therefore suggest that the side chain of
Asp132 might have a raised pKa in this conformation
of the enzyme, and that protonation and deprotona-
tion of Asp132 during the catalytic cycle might be
associated with the transition between occluded and
open states of dIII. Site-directed mutagenesis on the
equivalent aspartate residue of the intact E. coli en-
zyme (LAsp392) led to severely inhibited transhydro-
genation [42,43]. Interestingly, the complex between
expressed LAsp392Cys ecdIII and rrdI catalysed ‘re-
verse’ transhydrogenation ten times faster than wild-
type ecdIII:rrdI [37]. This suggests that the nucleo-
tide dissociates more readily from the mutant.
There are two possibilities for coupling the proton-
ation and deprotonation of Asp132 with the trans-
location of protons through dII. First, the protons
from dII might enter dIII, in the vicinity of helix D/
loop D and loop E, and bind directly to the aspar-
Fig. 5. Stereo view of the proposed dI:dIII binding surface. A Van der Waals model of residues 29^203 of rrdIII is presented. Bound
NADP is shown in green, with the nicotinamide ring to the right. The eight residues whose backbone amides broaden upon addition
of dI [15] are shown in yellow. Helix D/loop D protrudes from the right-hand side of the molecule.
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tate. Second, changes in the ionisation state of
Asp132 might arise indirectly, as a result of a con-
formational change propagated from dII through he-
lix D/loop D and loop E. At present there is no
biochemical evidence to favour one mechanism
over the other, but we suggest that protonation
and deprotonation events, however they are accom-
plished, play an essential role in controlling the rate
of product release from dIII.
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